Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → HCID 69418526, Verbindung

HRID 1375086Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1375086
[CH3:1][C:2]1[C:7]2[N:8]=[C:9]([NH:11][C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=3[CH3:18])[O:10][C:6]=2[CH:5]=[C:4]([CH2:19][C:20](O)=[O:21])[CH:3]=1.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.FC(F)(F)C(O)=O.[CH3:54][O:55][C:56](=[O:71])[CH2:57][C:58]1([C:64]2[CH:69]=[CH:68][C:67]([NH2:70])=[CH:66][CH:65]=2)[CH2:63][CH2:62][O:61][CH2:60][CH2:59]1>CN(C)C=O.C(N(C(C)C)CC)(C)C>[CH3:54][O:55][C:56](=[O:71])[CH2:57][C:58]1([C:64]2[CH:65]=[CH:66][C:67]([NH:70][C:20](=[O:21])[CH2:19][C:4]3[CH:3]=[C:2]([CH3:1])[C:7]4[N:8]=[C:9]([NH:11][C:12]5[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=5[CH3:18])[O:10][C:6]=4[CH:5]=3)=[CH:68][CH:69]=2)[CH2:59][CH2:60][O:61][CH2:62][CH2:63]1

Komponenten

6

Edukt 3

HCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 18188094(4-Methyl-2-o-tolylamino-benzoxazol-6-yl)-acetic acidHCID 69420032HCID 69420032, Verbindung

Produkt 1

HCID 69418526HCID 69418526, VerbindungAusbeute 90 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittel2×HCID 81531DiisopropylethylamineLösungsmittel2×

Versuchsvorschrift

A stirred solution of (4-methyl-2-o-tolylamino-benzoxazol-6-yl)-acetic acid [0.44 g, prepared according to the procedure described in International Patent Application No. WO00/61580 for Reference Example 9] in dry dimethylformamide (10 mL), under argon, was treated with O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (0.8477 g) and then with diisopropylethylamine (1.05 mL). After stirring at room temperature for 10 minutes the bright yellow solution was added to a solution of [4-{4-amino-phenyl}-tetrahydro-pyran-4-yl]-acetic acid methyl ester trifluoroacetate (0.444 g, Reference Example 18) in a mixture of dimethylformamide (8 mL) and diisopropylethylamine (1.05 mL). The mixture was stirred at room temperature under argon overnight and then evaporated to low bulk. The residue was dissolved in ethyl acetate and this solution was washed with water, then with aqueous sodium bicarbonate solution, and then with water and then evaporated. The residue was subjected to reverse phase HPLC on a Hypersil Elite C18 column using as the mobile phase a mixture of acetonitrile, water and trifluoroacetic acid (35:65:0.1, v/v/v) followed by a 1% acetonitrile/minute gradient to give the title compound (0.178 g, approximately 90% purity) which was used without further purification. LC-MS: RT=3.71 minutes, MS(ES+): 528(M+H)+.

Aufarbeitung

  1. stirringThe mixture was stirred at room temperature under argon overnight
  2. customevaporated to low bulk
  3. dissolutionThe residue was dissolved in ethyl acetate
  4. washthis solution was washed with water
  5. customwith aqueous sodium bicarbonate solution, and then with water and then evaporated
  6. additiona mixture of acetonitrile, water and trifluoroacetic acid (35:65:0.1, v/v/v)

Quellen und Nachweise

ORD-Eintrag
ord-5171c14d1ee04a21a5c584976aafd1eb
Quelldatensatz
uspto-grants-2007_01
Patentnummer
US07166616B2

Notizen zur Reaktion

Wird geladen…